Ductal Carcinoma in situ in Combination with Inflammatory Breast Syndrome: the Rare Clinical Case
https://doi.org/10.52560/2713-0118-2023-3-60-74
Abstract
Ductal carcinoma in situ (DCIS) is a breast carcinoma (BC) consisting of malignant cells in the ductal lumen of the breast without invasion beyond the epithelial membrane. The article presents a rare clinical case of the combined course of chronic mastitis and ductal carcinoma in situ in a 47-year-old female patient who was diagnosed with chronic mastitis during instrumental examination, and only after trepan biopsy and subsequent histological examination, intraductal breast cancer in situ was verified. This may indicate that instrumental methods and techniques are insufficiently informative in diagnosing ductal carcinoma in situ against the background of chronic mastitis.
About the Authors
T. V. Pavlova
City Clinical Hospital named after V. M. Buyanov; Central Research Institute of Radiation Diagnostics
Russian Federation
Russian Federation
Pavlova Tamara Valer’evna, Radiologyst of Department of Radiation Diagnostic; М. D. Med., Senior Researcher of Central Radiology Institute
26, ul. Bakinskaya, Moscow, 115516
+7 (916) 483-14-92
E. V. Shivilov
A. S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department
Russian Federation
Russian Federation
Shivilov Evgeny Vitalievich, Ph.D.
86, Entusiastov Shosse, Moscow, 111123
+7 (985) 109-36-40
K. A. Anichkina
A. S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department
Russian Federation
Russian Federation
Anichkina Kristina Arsen’evna, Research laboratory Assistant, Resident of Surgery
86, Entusiastov Shosse, Moscow, 111123
+7 (929) 989-01-91
D. D. Yurkanova
I. M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Yurkanova Darina Dmitrievna, 5th year student of the Institute of Clinical Medicine
8-2, ul. Trubetskaya, Moscow, 119991
+7 (929) 925-38-23
N. S. Karnaukhov
A. S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department
Russian Federation
Russian Federation
Karnaukhov Nikolay Sergeevich, Ph.D., Head of Pathology Department, Senior Researcher
86, Entuziastov Shosse, Moscow, 11123
+7 (918) 525-53-25
References
1. Aliyeva G. S., Korzhenkova G. P., Kolyadina I. V. Analysis of key radiological characteristics of early invasive breast cancer stages T1a-bN0M0 and DCIS. Onkol. zhurn.: luchevaya diagnostika, luchevaya terapiya. 2021;4(1):9-19. (In Russ.).
2. Zhukova L. G., Andreyeva Yu. Yu., Zavalishina L. E. et al. Breast cancer. Sovremennaya Onkologiya. 2021;23(1):5- 40. (In Russ).
3. Kaprin A. D., Starinskiy V. V., Shakhzadova A. O. State of Cancer Care for the Population of Russia in 2021. Moscow: Herzen Scientific Research Institute of Oncology and Radiology, Russian Ministry of Health, 2022. 239 с. (In Russ.).
4. American Cancer Society, Inc. 2023. URL: https://clck.ru/33ggu7
5. Balleyguier C., Dunant A., Ceugnart L. et al. (2019). Preoperative Breast Magnetic Resonance Imaging in Women With Local Ductal Carcinoma in Situ to Optimize Surgical Outcomes: Results From the Randomized Phase III Trial IRCIS. Journal of Clinical Oncology, JCO.18.00595. DOI: 10.1200/jco.18.00595
6. Bartram A., Gilbert F., Thompson A., Mann G. B., Agrawal A. (2021) Breast MRI in DCIS size estimation, breast-conserving surgery and oncoplastic breast surgery. Cancer Treat. Rev. 94:102158.
7. Burstein H. J., Polyak K., Wong J. S., Lester S. C., Kaelin C. M. Ductal carcinoma in situ of the breast. N. Engl. J. Med. 2004;350:1430-1441.
8. Cserni G., Sejben A. Grading Ductal carcinoma in situ (DCIS) of the breast – what’s wrong with it? Pathol. Oncol. Res. 2020;26:665-71. DOI: 10.1007/s12253-019-00760-8
9. Global cancer Observatory: cancer today. GLOBOCAN. Lyon, France: International Agency for Research on Cancer, 2020. URL: https://gco.iarc.fr/. Accesed October, 2022.
10. Healy N. A., Parag Y., Soppelsa G. et al. Does pre-operative breast MRI have an impact on surgical outcomes in high-grade DCIS? Br. J. Radiol. 2022;95(1138):20220306. DOI: 10.1259/bjr.20220306
11. Pinder S. E. Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation. Mod. Pathol. 2010; 23 (Suppl 2): S8-S13.
12. Qu N., Luo Y., Yu T. Differentiation between Clinically Noninflammatory Granulomatous Lobular Mastitis and Noncalcified Ductal Carcinoma in situ Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Breast Care (Basel). 2020;15(6):619-627. DOI:10.1159/000506068
13. Salvatorelli L., Puzzo L., Vecchio G. M. et al. Ductal carcinoma in situ of the breast: an update with emphasis on radiological and morphological features as predictive prognostic factors. Cancers (Basel). 2020;12(3):609. DOI:10.3390/cancers12030609
14. Stomper P. C., Connolly J. L., Meyer J. E., Harris J. R. Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic pathologic correlation. Radiology. 1989;172:235-241.
15. van Bekkum S., Ter Braak B. P. M., Plaisier P W., van Rosmalen J., Menke-Pluijmers M. B. E., Westenend P. J. Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS). Eur. J. Surg. Oncol. 2020;46(10 Pt A):1854-1860. DOI:10.1016/j.ejso.2020.05.028
16. Virnig B. A., Tuttle T. M., Shamliyan T., Kane R. L. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J. Natl. Cancer Inst. 2010 Feb 3;102(3):170-8. DOI:10.1093/jnci/djp482. Epub 2010 Jan 13. PMID: 20071685
17. Ward W. H., DeMora L., Handorf E. et al. Preoperative delays in the treatment of DCIS and the associated incidence of invasive breast cancer. Ann. Surg. Oncol. 2020;27(2):386-96. DOI: 10.1245/s10434-019-07844-4
18. Yang Y., Huang Y., Li P. et al. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2018;43(10):1123-1130. https://doi.org/10.11817/j.issn.1672-7347.2018.10.013
19. Zulfiqar B., Appalaneni U., Ahmed B., Hassan A., Boddu P., Carey A. Idiopathic granulomatous mastitis mimicking inflammatory breast carcinoma: What are the odds? ID Cases. 2016; 6:83-84. DOI:10.1016/j.idcr.2016.10.006
Review
For citations:
Pavlova T.V., Shivilov E.V., Anichkina K.A., Yurkanova D.D., Karnaukhov N.S. Ductal Carcinoma in situ in Combination with Inflammatory Breast Syndrome: the Rare Clinical Case. Radiology - Practice. 2023;(3):60-74. (In Russ.) https://doi.org/10.52560/2713-0118-2023-3-60-74
Views:
833
Email this article 